Name | Number of supported studies | Average coverage | |
---|---|---|---|
goblet cell | 8 studies | 33% ± 12% | |
epithelial cell | 6 studies | 29% ± 7% | |
basal cell | 3 studies | 25% ± 4% |
Insufficient scRNA-seq data for expression of GALNT12 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 2152.15 | 965 / 966 | 99% | 37.41 | 523 / 527 |
stomach | 100% | 1740.34 | 359 / 359 | 99% | 30.24 | 282 / 286 |
pancreas | 99% | 565.99 | 326 / 328 | 97% | 30.78 | 172 / 178 |
thymus | 100% | 960.85 | 653 / 653 | 94% | 32.77 | 569 / 605 |
esophagus | 100% | 1161.18 | 1445 / 1445 | 90% | 20.94 | 165 / 183 |
lung | 96% | 570.15 | 554 / 578 | 90% | 17.69 | 1041 / 1155 |
bladder | 100% | 980.29 | 21 / 21 | 85% | 21.01 | 430 / 504 |
prostate | 79% | 281.56 | 194 / 245 | 79% | 21.31 | 398 / 502 |
kidney | 62% | 168.83 | 55 / 89 | 81% | 10.02 | 730 / 901 |
uterus | 54% | 134.50 | 91 / 170 | 79% | 15.95 | 364 / 459 |
skin | 72% | 221.67 | 1295 / 1809 | 49% | 3.96 | 230 / 472 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.59 | 1 / 1 |
ovary | 3% | 6.25 | 5 / 180 | 93% | 13.00 | 399 / 430 |
breast | 76% | 291.46 | 350 / 459 | 14% | 1.62 | 158 / 1118 |
adrenal gland | 55% | 123.74 | 143 / 258 | 19% | 1.45 | 44 / 230 |
adipose | 74% | 327.12 | 891 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 60% | 8.68 | 27 / 45 |
eye | 0% | 0 | 0 / 0 | 55% | 3.32 | 44 / 80 |
lymph node | 0% | 0 | 0 / 0 | 52% | 3.66 | 15 / 29 |
spleen | 50% | 101.02 | 120 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 42% | 121.73 | 560 / 1335 | 0% | 0 | 0 / 0 |
brain | 29% | 371.57 | 755 / 2642 | 5% | 0.30 | 34 / 705 |
peripheral blood | 12% | 26.70 | 110 / 929 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 9% | 0.90 | 36 / 406 |
heart | 7% | 14.36 | 57 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 2.34 | 9 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016266 | Biological process | O-glycan processing |
GO_0006493 | Biological process | protein O-linked glycosylation |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0004653 | Molecular function | polypeptide N-acetylgalactosaminyltransferase activity |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | GALNT12 |
Protein name | Polypeptide N-acetylgalactosaminyltransferase 12 Alternative protein GALNT12 Polypeptide N-acetylgalactosaminyltransferase 12 (EC 2.4.1.41) (Polypeptide GalNAc transferase 12) (GalNAc-T12) (pp-GaNTase 12) (Protein-UDP acetylgalactosaminyltransferase 12) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 12) |
Synonyms | |
Description | FUNCTION: Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor. Has activity toward non-glycosylated peptides such as Muc5AC, Muc1a and EA2, and no detectable activity with Muc2 and Muc7. Displays enzymatic activity toward the Gal-NAc-Muc5AC glycopeptide, but no detectable activity to mono-GalNAc-glycosylated Muc1a, Muc2, Muc7 and EA2. May play an important role in the initial step of mucin-type oligosaccharide biosynthesis in digestive organs. |
Accessions | L8EB63 ENST00000375011.4 [Q8IXK2-1] A0A087WT76 ENST00000610463.1 Q68VJ1 Q8IXK2 |